Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-23

FDA Approved: NEBIVOLOL — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nebivolol submitted by Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

SUPPL AP for NEBIVOLOL (NEBIVOLOL)